Back to VICTORY CAPITAL MANAGEMENT INC VICTORY CAPITAL MANAGEMENT INC

IOVAIOVA

Showing 8 of 31 quarters

Position history for VICTORY CAPITAL MANAGEMENT INCVICTORY CAPITAL MANAGEMENT INC's holdings in IOVANCE BIOTHERAPEUTICS INC

Yes. Victory Capital Management holds 44,843 shares of IOVA (Iovance Biotherapeutics), worth $186,547, as of its Q2 2026 13F filing. It increased the position by 4,380 shares (+10.8%) from Q1 2026. Victory Capital Management has held IOVA in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$186,547

Current Shares

44,843

Total Value Change

-$1.2M

Total Shares Change

-99,437

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
44,843
+10.8%
$186,5470.0%$4.16
25
2026-Q1
Increased
40,463
+3.8%
$142,0250.0%$3.51
23
2025-Q4
Increased
38,993
+15.7%
$106,4510.0%$2.73
25
2025-Q3
Increased
33,706
+4.1%
$73,1420.0%$2.17
15
2025-Q2
Increased
32,384
+1.0%
$55,7000.0%$1.72
14
2025-Q1
Decreased
32,051
-77.3%
$106,7300.0%$3.33
0
2024-Q4
Decreased
141,480
-1.9%
$1M0.0%$7.40
0
2024-Q3
Increased
144,280
+399.4%
$1.4M0.0%$9.39
41

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used